Metabolism of cholesterol, vitamin D3 and 20-hydroxyvitamin D3 incorporated into phospholipid vesicles by human CYP27A1

[1]  D. Baldisseri,et al.  Production of 22-Hydroxy Metabolites of Vitamin D3 by Cytochrome P450scc (CYP11A1) and Analysis of Their Biological Activities on Skin Cells , 2011, Drug Metabolism and Disposition.

[2]  F. Mackenzie,et al.  Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system , 2011, Proceedings of the National Academy of Sciences.

[3]  Duane D. Miller,et al.  20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells. , 2011, American journal of physiology. Cell physiology.

[4]  K. Palczewski,et al.  Structural Basis for Three-step Sequential Catalysis by the Cholesterol Side Chain Cleavage Enzyme CYP11A1* , 2010, The Journal of Biological Chemistry.

[5]  R. Tuckey,et al.  Metabolism of substrates incorporated into phospholipid vesicles by mouse 25-hydroxyvitamin D3 1α-hydroxylase (CYP27B1) , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[6]  Duane D. Miller,et al.  Products of Vitamin D3 or 7-Dehydrocholesterol Metabolism by Cytochrome P450scc Show Anti-Leukemia Effects, Having Low or Absent Calcemic Activity , 2010, PloS one.

[7]  Eric F. Johnson,et al.  Crystal structure of CYP24A1, a mitochondrial cytochrome P450 involved in vitamin D metabolism. , 2010, Journal of molecular biology.

[8]  A. Slominski,et al.  20,23‐dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF‐κB activity in human keratinocytes , 2009, Journal of cellular physiology.

[9]  L. Pfeffer,et al.  20-Hydroxycholecalciferol, Product of Vitamin D3 Hydroxylation by P450scc, Decreases NF-κB Activity by Increasing IκBα Levels in Human Keratinocytes , 2009, PloS one.

[10]  K. Gyllensten,et al.  Regulation of Human Vitamin D3 25-Hydroxylases in Dermal Fibroblasts and Prostate Cancer LNCaP Cells , 2009, Molecular Pharmacology.

[11]  Wei Li,et al.  Metabolism of 1α-hydroxyvitamin D3 by cytochrome P450scc to biologically active 1α,20-dihydroxyvitamin D3 , 2008, The Journal of Steroid Biochemistry and Molecular Biology.

[12]  A. Slominski,et al.  20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation. , 2008, The Journal of investigative dermatology.

[13]  Duane D. Miller,et al.  Pathways and products for the metabolism of vitamin D3 by cytochrome P450scc , 2008, The FEBS journal.

[14]  N. Bell,et al.  Mutational analysis of CYP27A1: assessment of 27-hydroxylation of cholesterol and 25-hydroxylation of vitamin D. , 2007, Metabolism: clinical and experimental.

[15]  M. Norlin,et al.  Enzymes in the conversion of cholesterol into bile acids. , 2007, Current molecular medicine.

[16]  A. Plotnikov,et al.  Structural analysis of CYP2R1 in complex with vitamin D3. , 2007, Journal of molecular biology.

[17]  Keiko Yamamoto,et al.  Characterization of rat and human CYP2J enzymes as Vitamin D 25-hydroxylases , 2006, Steroids.

[18]  M. Holick.  Resurrection of vitamin D deficiency and rickets. , 2006, The Journal of clinical investigation.

[19]  Glenville Jones,et al.  Promise of vitamin D analogues in the treatment of hyperproliferative conditions , 2006, Molecular Cancer Therapeutics.

[20]  Wei Li,et al.  The cytochrome P450scc system opens an alternate pathway of vitamin D3 metabolism , 2005, The FEBS journal.

[21]  R. Tuckey.  Progesterone synthesis by the human placenta. , 2005, Placenta.

[22]  A. Norman,et al.  Effect of 25-hydroxyl group orientation on biological activity and binding to the 1α,25-dihydroxy vitamin D3 receptor , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[23]  G. Ansari,et al.  Phospholipids modify substrate binding and enzyme activity of human cytochrome P450 27A1 Published, JLR Papers in Press, September 1, 2004. DOI 10.1194/jlr.M400300-JLR200 , 2004, Journal of Lipid Research.

[24]  K. Inouye,et al.  Metabolism of vitamin D by human microsomal CYP2R1. , 2004, Biochemical and biophysical research communications.

[25]  Jeffrey B. Cheng,et al.  Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[26]  I. Pikuleva,et al.  Novel sterols synthesized via the CYP27A1 metabolic pathway. , 2003, Archives of biochemistry and biophysics.

[27]  R. Estabrook,et al.  A pathway for the metabolism of vitamin D3: Unique hydroxylated metabolites formed during catalysis with cytochrome P450scc (CYP11A1) , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Wilce,et al.  The F-G loop region of cytochrome P450scc (CYP11A1) interacts with the phospholipid membrane. , 2003, Biochimica et biophysica acta.

[29]  Werner Braun,et al.  Membrane-Protein Interactions Contribute to Efficient 27-Hydroxylation of Cholesterol by Mitochondrial Cytochrome P450 27A1* , 2002, The Journal of Biological Chemistry.

[30]  M. Holick.  Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health , 2002 .

[31]  I. Schuster,et al.  Skin is an autonomous organ in synthesis, two-step activation and degradation of vitamin D3: CYP27 in epidermis completes the set of essential vitamin D3-hydroxylases , 2001, Steroids.

[32]  L. Valiquette,et al.  Expression of CYP27A, a gene encoding a vitamin D‐25 hydroxylase in human liver and kidney , 2001, Clinical endocrinology.

[33]  K. Inouye,et al.  Metabolism of vitamin D3 by human CYP27A1. , 2000 .

[34]  M. L. Greenberg,et al.  The biosynthesis and functional role of cardiolipin. , 2000, Progress in lipid research.

[35]  M. Waterman,et al.  An Additional Electrostatic Interaction between Adrenodoxin and P450c27 (CYP27A1) Results in Tighter Binding Than between Adrenodoxin and P450scc (CYP11A1)* , 1999, The Journal of Biological Chemistry.

[36]  M. Waterman,et al.  Activities of Recombinant Human Cytochrome P450c27 (CYP27) Which Produce Intermediates of Alternative Bile Acid Biosynthetic Pathways* , 1998, The Journal of Biological Chemistry.

[37]  R. Tuckey,et al.  Expression of catalytically active human cytochrome p450scc in Escherichia coli and mutagenesis of isoleucine-462. , 1998, Archives of biochemistry and biophysics.

[38]  M. Waterman,et al.  Expression, purification, and enzymatic properties of recombinant human cytochrome P450c27 (CYP27). , 1997, Archives of biochemistry and biophysics.

[39]  A. Galloway,et al.  Sterol 27-hydroxylase: expression in human arterial endothelium. , 1997, Journal of lipid research.

[40]  E. Axén,et al.  Liver mitochondrial cytochrome P450 CYP27 and recombinant-expressed human CYP27 catalyze 1 alpha-hydroxylation of 25-hydroxyvitamin D3. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[41]  K. Okuda.  Liver mitochondrial P450 involved in cholesterol catabolism and vitamin D activation. , 1994, Journal of lipid research.

[42]  N. Javitt,et al.  Bile acid and sterol solubilization in 2-hydroxypropyl-beta-cyclodextrin. , 1992, Journal of lipid research.

[43]  D. Russell,et al.  Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis. , 1991, The Journal of biological chemistry.

[44]  D. Bikle,et al.  1,25-Dihydroxyvitamin D3 production by human keratinocytes. Kinetics and regulation. , 1986, The Journal of clinical investigation.

[45]  R. Tuckey,et al.  Purification and analysis of phospholipids in the inner mitochondrial membrane fraction of bovine corpus luteum, and properties of cytochrome P-450scc incorporated into vesicles prepared from these phospholipids. , 1985, European journal of biochemistry.

[46]  H. Kamin,et al.  Kinetics of the incorporation of adrenal cytochrome P-450scc into phosphatidylcholine vesicles. , 1982, The Journal of biological chemistry.

[47]  Y. Ichikawa,et al.  Purification of cytochrome P-450D1α (25-hydroxyvitamin D3-1α-hydroxylase) of bovine kidney mitochondria , 1982 .

[48]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.

[49]  T. Omura,et al.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. , 1964, The Journal of biological chemistry.

[50]  H. Pols,et al.  Vitamin D , 1928, Calcified Tissue International.

[51]  A. Slominski,et al.  Kinetics of vitamin D3 metabolism by cytochrome P450scc (CYP11A1) in phospholipid vesicles and cyclodextrin. , 2008, The international journal of biochemistry & cell biology.

[52]  B. Sternberg,et al.  Incorporation of vitamin D3-derivatives in liposomes of different lipid types. , 1994, Journal of drug targeting.